Prestige Wealth Management Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3
| Closed | -$1.08K | – | 1027 |
|
|
2023
Q3 | $1.08K | Hold |
3
| – | – | ﹤0.01% | 869 |
|
|
2023
Q2 | $1.14K | Sell |
3
-1
| -25% | -$379 | ﹤0.01% | 888 |
|
|
2023
Q1 | $1.92K | Sell |
4
-6
| -60% | -$2.88K | ﹤0.01% | 750 |
|
|
2022
Q4 | $4.21K | Buy |
10
+9
| +900% | +$3.79K | ﹤0.01% | 656 |
|
|
2022
Q3 | $0 | Buy |
+1
| New | – | ﹤0.01% | 972 |
|
|
2022
Q2 | – | Sell |
-20
| Closed | -$11K | – | 979 |
|
|
2022
Q1 | $11K | Sell |
20
-6
| -23% | -$3.3K | ﹤0.01% | 437 |
|
|
2021
Q4 | $20K | Hold |
26
| – | – | ﹤0.01% | 378 |
|
|
2021
Q3 | $19K | Hold |
26
| – | – | ﹤0.01% | 378 |
|
|
2021
Q2 | $17K | Buy |
26
+9
| +53% | +$5.89K | ﹤0.01% | 375 |
|
|
2021
Q1 | $9K | Buy |
17
+6
| +55% | +$3.18K | ﹤0.01% | 487 |
|
|
2020
Q4 | $6K | Buy |
+11
| New | +$6K | ﹤0.01% | 527 |
|
|
2019
Q1 | – | Sell |
-2
| Closed | – | – | 569 |
|
|
2018
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1245 |
|